Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Journal of the American Chemical Society
|
March 9, 2012
Single reporter for targeted multimodal in vivo imaging
Johanna M Niers, John W Chen, Grant Lewandrowski, et al.
Scientific Reports
|
November 28, 2015
Multimodal targeted high relaxivity thermosensitive liposome for in vivo imaging
Maayke M P Kuijten, M Hannah Degeling, John W Chen, et al.
Journal of Neuro-Oncology
|
April 24, 2009
Genetically engineered T cells to target EGFRvIII expressing glioblastoma
Szofia S Bullain, Ayguen Sahin, Oszkar Szentirmai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 18, 2009
Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors
Matthias Nahrendorf, Peter Waterman, Greg Thurber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 14, 2010
Hybrid PET-optical imaging using targeted probes
Matthias Nahrendorf, Edmund Keliher, Brett Marinelli, et al.
Molecular Neurobiology
|
May 30, 2018
Multimodal Molecular Imaging Demonstrates Myeloperoxidase Regulation of Matrix Metalloproteinase Activity in Neuroinflammation
Yinian Zhang, Huateng Dong, Daniel P Seeburg, et al.
Neoplasia (New York, N.Y.)
|
May 5, 2009
Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle
Antoine Leimgruber, Cedric Berger, Virna Cortez-Retamozo, et al.
The Journal of Clinical Investigation
|
November 27, 2008
Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation
Virna Cortez-Retamozo, Filip K Swirski, Peter Waterman, et al.
Science (New York, N.Y.)
|
August 1, 2009
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
Filip K Swirski, Matthias Nahrendorf, Martin Etzrodt, et al.
Journal of Neuro-Oncology
|
August 10, 2012
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy
J Dawn Waters, Carlos Sanchez, Ayguen Sahin, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Journal of the American Chemical Society
|
March 9, 2012
Single reporter for targeted multimodal in vivo imaging
Johanna M Niers, John W Chen, Grant Lewandrowski, et al.
Scientific Reports
|
November 28, 2015
Multimodal targeted high relaxivity thermosensitive liposome for in vivo imaging
Maayke M P Kuijten, M Hannah Degeling, John W Chen, et al.
Journal of Neuro-Oncology
|
April 24, 2009
Genetically engineered T cells to target EGFRvIII expressing glioblastoma
Szofia S Bullain, Ayguen Sahin, Oszkar Szentirmai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 18, 2009
Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors
Matthias Nahrendorf, Peter Waterman, Greg Thurber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 14, 2010
Hybrid PET-optical imaging using targeted probes
Matthias Nahrendorf, Edmund Keliher, Brett Marinelli, et al.
Molecular Neurobiology
|
May 30, 2018
Multimodal Molecular Imaging Demonstrates Myeloperoxidase Regulation of Matrix Metalloproteinase Activity in Neuroinflammation
Yinian Zhang, Huateng Dong, Daniel P Seeburg, et al.
Neoplasia (New York, N.Y.)
|
May 5, 2009
Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle
Antoine Leimgruber, Cedric Berger, Virna Cortez-Retamozo, et al.
The Journal of Clinical Investigation
|
November 27, 2008
Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation
Virna Cortez-Retamozo, Filip K Swirski, Peter Waterman, et al.
Science (New York, N.Y.)
|
August 1, 2009
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
Filip K Swirski, Matthias Nahrendorf, Martin Etzrodt, et al.
Journal of Neuro-Oncology
|
August 10, 2012
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy
J Dawn Waters, Carlos Sanchez, Ayguen Sahin, et al.
Page
of 4